catechin has been researched along with Bone Loss, Osteoclastic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, S; Honda, Y; Huang, A; Li, P; Tanaka, T | 1 |
| Kamada, T; Kubo, T; Nishioku, T; Okamoto, K; Shoyama, Y; Tsukuba, T; Uto, T | 1 |
| Hsiao, HB; Lin, WC; Wu, JB | 1 |
| Peng, B; Wang, Y; Yu, J; Zhu, L; Zhu, S | 1 |
| Ishii, M; Iwamoto, Y; Kato, S; Katsuoka, F; Kawaguchi, S; Kobayashi, Y; Nakamura, T; Nishikawa, K; Takayanagi, H; Tsujita, T; Yamamoto, M | 1 |
| Amano, H; Emori, H; Iwai, S; Kobayashi, T; Oguchi, K; Oguchi, T; Ohura, K; Ryu, K; Sambe, T | 1 |
| Gan, M; Geng, D; Hu, X; Ping, Z; Shi, J; Tao, Y; Wang, L; Wang, Z; Wu, X; Xu, Y; Yang, H; Zhang, W | 1 |
| Ha, H; Jin, H; Kim, HN; Lee, JH; Lee, ZH; Shim, HE | 1 |
| Kim, BJ; Kim, GH; Kim, GS; Kim, SW; Kim, YS; Koh, JM; Lee, KU; Lee, SH; Lee, SY; Lee, YS | 1 |
| Cho, SW; Choi, HJ; Kim, BJ; Kim, GS; Kim, HH; Koh, JM; Lee, SH; Lee, SY; Lee, YS; Park, SY; Shin, CS | 1 |
| Choi, JH; Kim, JK; Park, KY; Rhee, IK; Rhee, SJ | 1 |
| Chai, JK; Cho, KS; Choi, SH; Kim, CK; Kim, CS; Yun, JH | 1 |
| Barnes, S; Ferruzzi, MG; Janle, EM; Kim, H; Lila, MA; Morré, DJ; Morré, DM; Simon, JE; Weaver, CM; Wyss, JM | 1 |
| Delaissé, JM; Eeckhout, Y; Vaes, G | 1 |
1 review(s) available for catechin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Botanicals for age-related diseases: from field to practice.
Topics: Aging; Antioxidants; Biological Availability; Blood Vessels; Bone Resorption; Catechin; Cognition; Cognition Disorders; Flavonoids; Health; Humans; Neoplasms; Oxidative Stress; Phenols; Polyphenols | 2008 |
13 other study(ies) available for catechin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Integration of Epigallocatechin Gallate in Gelatin Sponges Attenuates Matrix Metalloproteinase-Dependent Degradation and Increases Bone Formation.
Topics: Absorbable Implants; Aldehydes; Animals; Biocompatible Materials; Bone Regeneration; Bone Resorption; Catechin; Cell Line; Cell Proliferation; Gelatin; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Osteoblasts; Rats; Rats, Sprague-Dawley; Skull; Tissue Engineering; Tissue Scaffolds; X-Ray Microtomography | 2019 |
(-)-Epigallocatechin-3-gallate inhibits RANKL-induced osteoclastogenesis via downregulation of NFATc1 and suppression of HO-1-HMGB1-RAGE pathway.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Resorption; Catechin; Cathepsin K; Cell Differentiation; CSK Tyrosine-Protein Kinase; Femur; Gene Expression Regulation; Heme Oxygenase-1; HMGB1 Protein; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; Primary Cell Culture; RANK Ligand; Receptor for Advanced Glycation End Products; Signal Transduction; Tibia; Treatment Outcome; Vacuolar Proton-Translocating ATPases | 2020 |
(-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.
Topics: Animals; Bone Resorption; Catechin; Female; Ferns; Mice; Mice, Inbred ICR; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteoporosis; Ovariectomy; Phytotherapy; Plant Extracts; RANK Ligand; RAW 264.7 Cells; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction | 2017 |
Anti-osteoclastogenic effect of epigallocatechin gallate-functionalized gold nanoparticles in vitro and in vivo.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Catechin; Cell Death; Density Functional Theory; Down-Regulation; Drug Liberation; Drug Stability; Gold; Ligands; Lipopolysaccharides; Macrophages; Male; Metal Nanoparticles; Mice, Inbred BALB C; Models, Biological; Osteogenesis; RANK Ligand; Reactive Oxygen Species; Signal Transduction; Skull; Transcription, Genetic | 2019 |
DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway.
Topics: Animals; Biflavonoids; Bone Resorption; Catechin; Cell Differentiation; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Down-Regulation; Gene Expression; Mice; Osteoclasts; Osteogenesis; RANK Ligand; S-Adenosylmethionine; Transcription Factors | 2015 |
A new method for measuring osteoclast formation by electrical impedance.
Topics: Bone Resorption; Catechin; Cell Differentiation; Cells, Cultured; Computer Systems; Cytological Techniques; Electric Impedance; Humans; Macrophage Colony-Stimulating Factor; Osteoclasts; RANK Ligand | 2015 |
Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Topics: Animals; Biflavonoids; Bone Resorption; Catechin; Gene Expression Regulation; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Osteoclasts; Osteogenesis; Osteolysis; RANK Ligand; RAW 264.7 Cells; Skull; Titanium | 2017 |
Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Catechin; Cells, Cultured; Coculture Techniques; Down-Regulation; Gene Expression Regulation; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteoprotegerin; Proto-Oncogene Proteins c-fos; RANK Ligand; Signal Transduction | 2010 |
AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts.
Topics: Adenylate Kinase; Animals; Apoptosis; Blotting, Western; Bone Resorption; Catechin; Cell Differentiation; Cell Survival; Cells, Cultured; Macrophage Colony-Stimulating Factor; MAP Kinase Kinase Kinases; Metformin; Mice; Mice, Inbred ICR; Osteoclasts; Osteogenesis; Pyrazoles; Pyrimidines; RANK Ligand; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Stilbenes | 2010 |
(-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption.
Topics: AMP-Activated Protein Kinases; Animals; Body Weight; Bone Density; Bone Resorption; Catechin; Enzyme Activators; Female; Mice; Ovariectomy; Protease Inhibitors | 2012 |
Action of green tea catechin on bone metabolic disorder in chronic cadmium-poisoned rats.
Topics: Amino Acids; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Cadmium Poisoning; Calcium; Catechin; Chronic Disease; Creatinine; Dose-Response Relationship, Drug; Male; Osteocalcin; Rats; Rats, Sprague-Dawley; Tea | 2003 |
(-)-Epigallocatechin gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from RAW 264.7 cells.
Topics: Acid Phosphatase; Alveolar Process; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Bone Resorption; Caspase Inhibitors; Caspases; Catechin; Cell Line; Cell Survival; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Isoenzymes; Mice; Osteoclasts; RANK Ligand; Tartrate-Resistant Acid Phosphatase | 2007 |
Inhibition of bone resorption in culture by (+)-catechin.
Topics: Animals; Benzopyrans; Bone Resorption; Calcium; Catechin; Dinoprostone; Isoenzymes; L-Lactate Dehydrogenase; Mice; Organ Culture Techniques; Parathyroid Hormone; Prostaglandins E; Tretinoin | 1986 |